Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Prevalence of Multiple Sclerosis in the Republic of Moldova.
Neuroepidemiology. 2016;46(3):166-72. doi: 10.1159/000443931. Epub 2016 Feb 6.
Neuroepidemiology. 2016.
PMID: 26849377
Short- and long-term outcome and predictors in an international cohort of patients with neuro-COVID-19.
Beghi E, Helbok R, Ozturk S, Karadas O, Lisnic V, Grosu O, Kovács T, Dobronyi L, Bereczki D, Cotelli MS, Turla M, Davidescu EI, Popescu BO, Valzania F, Cavallieri F, Ulmer H, Maia LF, Amodt AH, Armon C, Brola W, Victoria G, Riahi A, Krehan I, von Oertzen T, Azab MA, Crean M, Lolich M, Lima MJ, Sellner J, Perneczky J, Jenkins T, Meoni S, Bianchi E, Moro E, Bassetti CLA; ENERGY Study Group.
Beghi E, et al.
Eur J Neurol. 2022 Jun;29(6):1663-1684. doi: 10.1111/ene.15293. Epub 2022 Mar 7.
Eur J Neurol. 2022.
PMID: 35194889
Free PMC article.
Item in Clipboard
Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study.
Miller DH, Fox RJ, Phillips JT, Hutchinson M, Havrdova E, Kita M, Wheeler-Kingshott CA, Tozer DJ, MacManus DG, Yousry TA, Goodsell M, Yang M, Zhang R, Viglietta V, Dawson KT; CONFIRM study investigators.
Miller DH, et al.
Neurology. 2015 Mar 17;84(11):1145-52. doi: 10.1212/WNL.0000000000001360. Epub 2015 Feb 13.
Neurology. 2015.
PMID: 25681448
Free PMC article.
Clinical Trial.
Item in Clipboard
Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis.
Gold R, Kappos L, Arnold DL, Bar-Or A, Giovannoni G, Selmaj K, Tornatore C, Sweetser MT, Yang M, Sheikh SI, Dawson KT; DEFINE Study Investigators.
Gold R, et al.
N Engl J Med. 2012 Sep 20;367(12):1098-107. doi: 10.1056/NEJMoa1114287.
N Engl J Med. 2012.
PMID: 22992073
Free article.
Clinical Trial.
Item in Clipboard
Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.
Fox RJ, Miller DH, Phillips JT, Hutchinson M, Havrdova E, Kita M, Yang M, Raghupathi K, Novas M, Sweetser MT, Viglietta V, Dawson KT; CONFIRM Study Investigators.
Fox RJ, et al.
N Engl J Med. 2012 Sep 20;367(12):1087-97. doi: 10.1056/NEJMoa1206328.
N Engl J Med. 2012.
PMID: 22992072
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite